FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980499812> ?p ?o ?g. }

• W1980499812 endingPage "51" @default.
• W1980499812 startingPage "47" @default.
• W1980499812 abstract "Increased rates of bowel perforation in patients with recurrent epithelial ovarian cancer (EOC) treated with bevacizumab have been reported, but the risk factors for this association are uncertain. We sought to identify factors associated with bowel perforation and fistula formation in recurrent EOC patients treated with bevacizumab.A chart review of all patients treated with bevacizumab for recurrent EOC at a single institution was performed. Pertinent patient characteristics and treatment information were collected. Univariate logistic regression was performed to analyze multiple variables.One hundred twelve patients who were treated with 160 different bevacizumab regimens were identified. The median age was 60 years (range, 29-78 years). Patients had received a median of 4 prior chemotherapy regimens (range, 1-10). The median number of cycles was 4 (range, 0.5-31). Ten patients (9%) were diagnosed with bowel perforations, and another 2 patients (1.8%) were diagnosed with fistulas. The 30-day mortality following perforation was 50%, with 30% of patients dying within 1 week. Patients with rectovaginal nodularity were more likely to develop a bowel perforation or fistula than those who did not have this finding, OR=3.64 (95% CI=1.1 to 12.1, p=0.04). None of the other variables were significantly associated with bowel perforations or fistula formation.Rectovaginal nodularity is associated with an increased risk of bowel perforation or fistula formation for patients with recurrent EOC treated with bevacizumab. Careful consideration should be given prior to initiating bevacizumab treatment in EOC patients with rectovaginal nodularity since the mortality rate with bevacizumab associated bowel perforations is 50%." @default.
• W1980499812 created "2016-06-24" @default.
• W1980499812 creator A5006618032 @default.
• W1980499812 creator A5021359849 @default.
• W1980499812 creator A5030523401 @default.
• W1980499812 creator A5030705960 @default.
• W1980499812 creator A5059622280 @default.
• W1980499812 creator A5060497385 @default.
• W1980499812 creator A5090429618 @default.
• W1980499812 creator A5091030588 @default.
• W1980499812 date "2010-07-01" @default.
• W1980499812 modified "2023-10-17" @default.
• W1980499812 title "Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?" @default.
• W1980499812 cites W1980452371 @default.
• W1980499812 cites W1997611501 @default.
• W1980499812 cites W2003305754 @default.
• W1980499812 cites W2018929154 @default.
• W1980499812 cites W2041555738 @default.
• W1980499812 cites W2043103956 @default.
• W1980499812 cites W2047667511 @default.
• W1980499812 cites W2084555154 @default.
• W1980499812 cites W2096521047 @default.
• W1980499812 cites W2104938382 @default.
• W1980499812 cites W2105651363 @default.
• W1980499812 cites W2105782281 @default.
• W1980499812 cites W2121740300 @default.
• W1980499812 cites W2124863710 @default.
• W1980499812 cites W2125447919 @default.
• W1980499812 cites W2139248078 @default.
• W1980499812 cites W2156575195 @default.
• W1980499812 cites W2157769714 @default.
• W1980499812 cites W2157920585 @default.
• W1980499812 doi "https://doi.org/10.1016/j.ygyno.2010.01.011" @default.
• W1980499812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20382413" @default.
• W1980499812 hasPublicationYear "2010" @default.
• W1980499812 type Work @default.
• W1980499812 sameAs 1980499812 @default.
• W1980499812 citedByCount "37" @default.
• W1980499812 countsByYear W19804998122012 @default.
• W1980499812 countsByYear W19804998122013 @default.
• W1980499812 countsByYear W19804998122014 @default.
• W1980499812 countsByYear W19804998122015 @default.
• W1980499812 countsByYear W19804998122016 @default.
• W1980499812 countsByYear W19804998122017 @default.
• W1980499812 countsByYear W19804998122018 @default.
• W1980499812 countsByYear W19804998122019 @default.
• W1980499812 countsByYear W19804998122020 @default.
• W1980499812 countsByYear W19804998122021 @default.
• W1980499812 countsByYear W19804998122022 @default.
• W1980499812 countsByYear W19804998122023 @default.
• W1980499812 crossrefType "journal-article" @default.
• W1980499812 hasAuthorship W1980499812A5006618032 @default.
• W1980499812 hasAuthorship W1980499812A5021359849 @default.
• W1980499812 hasAuthorship W1980499812A5030523401 @default.
• W1980499812 hasAuthorship W1980499812A5030705960 @default.
• W1980499812 hasAuthorship W1980499812A5059622280 @default.
• W1980499812 hasAuthorship W1980499812A5060497385 @default.
• W1980499812 hasAuthorship W1980499812A5090429618 @default.
• W1980499812 hasAuthorship W1980499812A5091030588 @default.
• W1980499812 hasConcept C121608353 @default.
• W1980499812 hasConcept C126322002 @default.
• W1980499812 hasConcept C141071460 @default.
• W1980499812 hasConcept C144301174 @default.
• W1980499812 hasConcept C191897082 @default.
• W1980499812 hasConcept C192562407 @default.
• W1980499812 hasConcept C2776341189 @default.
• W1980499812 hasConcept C2776694085 @default.
• W1980499812 hasConcept C2777802072 @default.
• W1980499812 hasConcept C2778456384 @default.
• W1980499812 hasConcept C2778527123 @default.
• W1980499812 hasConcept C2779686005 @default.
• W1980499812 hasConcept C2780199535 @default.
• W1980499812 hasConcept C2780356529 @default.
• W1980499812 hasConcept C2780427987 @default.
• W1980499812 hasConcept C3018436397 @default.
• W1980499812 hasConcept C38180746 @default.
• W1980499812 hasConcept C526805850 @default.
• W1980499812 hasConcept C71924100 @default.
• W1980499812 hasConcept C81182388 @default.
• W1980499812 hasConcept C90924648 @default.
• W1980499812 hasConceptScore W1980499812C121608353 @default.
• W1980499812 hasConceptScore W1980499812C126322002 @default.
• W1980499812 hasConceptScore W1980499812C141071460 @default.
• W1980499812 hasConceptScore W1980499812C144301174 @default.
• W1980499812 hasConceptScore W1980499812C191897082 @default.
• W1980499812 hasConceptScore W1980499812C192562407 @default.
• W1980499812 hasConceptScore W1980499812C2776341189 @default.
• W1980499812 hasConceptScore W1980499812C2776694085 @default.
• W1980499812 hasConceptScore W1980499812C2777802072 @default.
• W1980499812 hasConceptScore W1980499812C2778456384 @default.
• W1980499812 hasConceptScore W1980499812C2778527123 @default.
• W1980499812 hasConceptScore W1980499812C2779686005 @default.
• W1980499812 hasConceptScore W1980499812C2780199535 @default.
• W1980499812 hasConceptScore W1980499812C2780356529 @default.
• W1980499812 hasConceptScore W1980499812C2780427987 @default.
• W1980499812 hasConceptScore W1980499812C3018436397 @default.
• W1980499812 hasConceptScore W1980499812C38180746 @default.
• W1980499812 hasConceptScore W1980499812C526805850 @default.

• next